Has Ann Jakubowski, MD received payments from drug or device companies?

Yes. Drug and device makers reported $122,604 in general payments to Ann Jakubowski, MD across 25 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ann Jakubowski, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ann Jakubowski, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ann Jakubowski, MD

Hematology · New York, NYNPI 1467555342

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $120,700 of the $122,604 with a category attached, or 98.4%. National Marrow Donor Program accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest. Among hematology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$122,604in general payments, 2019–2025

Across 25 payments — averaging $4904.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

National Marrow Donor Program$122K
Incyte Corporation$122

What the payments were for

Consulting fees$120,70098%
Travel & lodging$1,6361%
Food & beverage$2680%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
National Marrow Donor Program	24	$122,481
Incyte Corporation	1	$122

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NIKTIMVO$122

How this compares

$122,604 in reported general payments places this provider in the 90th percentile of 157 hematology providers in New York.

See all hematology providers in New York →

Medicare billing

Part B allowed, 2024

$58,702

Medicare patients

Services billed

428

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CresembaIsavuconazonium Sulfate	14	$99,586
PrevymisLetermovir	11	$77,509
NeupogenFilgrastim	11	$29,761
Acyclovir	98	$4,637
Tacrolimus	27	$2,186
Ursodiol	13	$1,816
Cyclosporine ModifiedCyclosporine, Modified	11	$1,045
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	37	$159
Pantoprazole Sodium	24	$98
Prednisone	16	$46

Paid to pharmacies, not to this prescriber.

Other hematology in New York

Barry CollerNew York$7.9M
Allyson OceanNew York$1.4M
Ahmed SawasNew York$618K
Jeffrey ZwickerNew York$561K
Dan DouerNew York$477K
Ran ReshefNew York$468K
Faith DaviesNew York$307K
Michael MauroNew York$229K
Richard FurmanNew York$208K
Adam KittaiNew York$89K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →